PRL and breast cancer: Experimental studies have shown that phosphorylation of STAT5 regulates the biological functions of prostate and breast cancer cells [16, 17, 24], and the JAK2/STAT5 cascade appears to be the only pathway activated by PRL in prostate [43, 44].